Acamprosate decreases the induction of tolerance and physical dependence in morphine-treated mice

European Journal of Pharmacology

Volumn 445, Issue 1-2, 2002, Pages 87-91

  Sepúlveda, Jacqueline ^a   Ortega, Andrea ^a   Zapata, Gladys ^a   Contreras, Enrique ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

Author keywords

Abstinence syndrome; Acamprosate; Morphine antinociception; Morphine dependence

Indexed keywords

ACAMPROSATE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG WITHDRAWAL; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ANIMALS; DRUG TOLERANCE; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; PAIN MEASUREMENT; TAURINE;

EID: 0037036210     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01767-3     Document Type: Article

References (23)

1. Mechanism of action of acamprosate: Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex
2. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats
3. Synthetic analgesics II dithienylbutenyl and dithienylbutyl amines
4. Decrease of tolerance to, and physical dependence on morphine by glutamate receptor antagonists
5. Influence of GABA on morphine analgesia, tolerance and physical dependence
6. Interpretation of voltage-clamp measurements in hippocampal neurons
7. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibres. Modulation by μ-opioids
8. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats
9. Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics
10. 2 using microdialysis in conscious rats
11. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat
12. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice
13. Molecular and cellular basis of addiction
14. G monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine dependent mice
15. Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence
16. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: An in vivo microdialysis study
17. Riluzole decreases the abstinence syndrome and physical dependence in morphine dependent mice
18. Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes
19. Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress
20. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome
21. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
22. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity?
23. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: Binding at μ-opioid receptors